Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β

发表于 2026-8-19 14:03:44

期刊：Science Translational Medicine

文献作者：Yan Lan; Dong Zhang; Chunxiao Xu; Kenneth W. Hance; Bo Marelli; Jin Qi; Huakui Yu; Guozhong Qin; Aroop Sircar; Vivian M. Hernández; Molly H. Jenkins; Rachel E. Fontana; Amit Deshpande; George Locke; Helen Sabzevari; Laszlo Radvanyi; Kin-Ming Lo

出版日期：2018-1-17

DOI号：10.1126/scitranslmed.aan5488

下载链接：https://www.science.org/doi/pdf/10.1126/scitranslmed.aan5488

文献链接：https://doi.org/10.1126/scitranslmed.aan5488

当前文献来源于 American Association for the Advancement of Science (AAAS)。

备注信息：

发表于 2026-8-19 14:03:45

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[AAAS] Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[AAAS] Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β 一键复制